Fig. 3
From: Plasma lipoproteome in Alzheimer’s disease: a proof-of-concept study
Comparison of complement C3 peptide IHWESASLLR levels in VLDL, IDL, LDL, and HDL fractionated from plasma and in immunodepleted plasma obtained from AD cases (n = 5) and matched cognitively unimpaired controls (n = 5). Peptide levels were measured using MS-based targeted proteomics. Unadjusted p values are displayed at the top of each plot, the middle lines indicate means, and the bottom and top lines indicate SD bars